rs34850974

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001366385.1(CARD14):​c.2885G>A​(p.Arg962Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00802 in 1,559,890 control chromosomes in the GnomAD database, including 884 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R962W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.042 ( 491 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 393 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.740

Publications

5 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
SGSH (HGNC:10818): (N-sulfoglucosamine sulfohydrolase) This gene encodes the enzyme sulfamidase; one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with the lysosomal storage disease mucopolysaccaridosis IIIA, also known as Sanfilippo syndrome A, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jun 2017]
SGSH Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Orphanet, Myriad Women’s Health, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011251271).
BP6
Variant 17-80208215-G-A is Benign according to our data. Variant chr17-80208215-G-A is described in ClinVar as Benign. ClinVar VariationId is 458102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.2885G>A p.Arg962Gln missense_variant Exon 24 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.2885G>A p.Arg962Gln missense_variant Exon 24 of 24 NM_001366385.1 ENSP00000498071.1 Q9BXL6-1

Frequencies

GnomAD3 genomes
AF:
0.0423
AC:
6432
AN:
152160
Hom.:
489
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.0282
GnomAD2 exomes
AF:
0.0103
AC:
1738
AN:
168668
AF XY:
0.00783
show subpopulations
Gnomad AFR exome
AF:
0.149
Gnomad AMR exome
AF:
0.00684
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000414
Gnomad OTH exome
AF:
0.00439
GnomAD4 exome
AF:
0.00431
AC:
6061
AN:
1407612
Hom.:
393
Cov.:
32
AF XY:
0.00368
AC XY:
2560
AN XY:
694964
show subpopulations
African (AFR)
AF:
0.151
AC:
4923
AN:
32582
American (AMR)
AF:
0.00790
AC:
286
AN:
36222
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25216
East Asian (EAS)
AF:
0.0000268
AC:
1
AN:
37344
South Asian (SAS)
AF:
0.000300
AC:
24
AN:
80010
European-Finnish (FIN)
AF:
0.0000205
AC:
1
AN:
48666
Middle Eastern (MID)
AF:
0.00685
AC:
37
AN:
5398
European-Non Finnish (NFE)
AF:
0.000220
AC:
238
AN:
1083802
Other (OTH)
AF:
0.00944
AC:
551
AN:
58372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
259
518
776
1035
1294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0423
AC:
6446
AN:
152278
Hom.:
491
Cov.:
33
AF XY:
0.0414
AC XY:
3080
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.147
AC:
6113
AN:
41542
American (AMR)
AF:
0.0157
AC:
241
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68014
Other (OTH)
AF:
0.0279
AC:
59
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
285
570
855
1140
1425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0123
Hom.:
90
Bravo
AF:
0.0474
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.139
AC:
603
ESP6500EA
AF:
0.00106
AC:
9
ExAC
AF:
0.0103
AC:
1192
Asia WGS
AF:
0.00895
AC:
32
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 04, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.47
DANN
Benign
0.81
DEOGEN2
Benign
0.012
T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0089
N
LIST_S2
Benign
0.65
.;.;T
MetaRNN
Benign
0.0011
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;L;L
PhyloP100
-0.74
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.36
.;.;N
REVEL
Benign
0.028
Sift
Benign
0.24
.;.;T
Sift4G
Benign
0.15
T;.;T
Polyphen
0.0
B;B;B
Vest4
0.067
MPC
0.17
ClinPred
0.0022
T
GERP RS
-7.3
Varity_R
0.022
gMVP
0.20
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34850974; hg19: chr17-78182014; API